newsfilter
← Latest News
GlobeNewswire·

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

PHILADELPHIA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (NASDAQ:CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed